| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 332,415 | 345,849 | 326,270 | 366,240 | | Cost of Revenue | 151,093 | 154,977 | 152,662 | 165,744 | | | Gross Profit | 181,322 | 190,872 | 173,608 | 200,496 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 139,637 | 138,696 | 110,865 | 161,735 | | Non Recurring |
-
| 294,529 |
-
|
-
| | Others | 10,103 | 10,236 | 10,710 | 10,778 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 31,582 | (252,589) | 52,033 | 27,983 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 10 | 308 | 121 | 107 | | Earnings Before Interest And Taxes | 31,592 | (252,281) | 52,154 | 28,090 | | Interest Expense | 5,041 | 5,079 | 4,911 | 5,353 | | Income Before Tax | 26,551 | (257,360) | 47,243 | 22,737 | | Income Tax Expense | 8,210 | (93,508) | 17,078 | 10,194 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 18,341 | (163,852) | 30,165 | 12,543 | | | Non-recurring Events | | Discontinued Operations |
-
| 160 | (4,737) |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 18,341 | (163,692) | 25,428 | 12,543 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $18,341 | ($163,692) | $25,428 | $12,543 |
|
0.61% Nasdaq 
0.09%
Income Statement
